Market Overview:
The global transfusion diagnostic equipment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of blood-borne diseases, growing demand for safe and effective blood transfusions, and technological advancements in transfusion diagnostic equipment. The global transfusion diagnostic equipment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into molecular HLA typing diagnose equipment, HLA serology diagnose equipment, and HLA antibody diagnostics equipments. The molecular HLA typing diagnose equipments segment is expected to grow at a CAGR of 7% during the forecast period from 2018 to 2030 due to its ability to detect minute genetic variations that can cause serious health problems in patients receiving blood transfusions. On the basis of application,the market is divided into pre-transfusion diagnostic and post-transfusion diagnostic segments. The pre-transfusion diagnostic segment dominates this market owingto its abilityto identify potential donors for blood donationand prevent transmissionof infections throughblood donations .
Product Definition:
Transfusion Diagnostic Equipment is a device used to measure the amount of hemoglobin in a blood sample. Hemoglobin is important because it helps red blood cells deliver oxygen throughout the body.
Molecular HLA Typing Diagnose Equipment:
HLA typing is a technique used for identification of the major histocompatibility complex (MHC) on the basis of DNA sequence. This test helps in matching antibodies with donor blood and transfusion. It also helps in minimizing risk associated with blood transfusions such as graft versus host disease, hemolytic disease, and infectious diseases.
HLA Serology Diagnose Equipment:
HLA serology diagnosis is used for detecting antibodies in the blood. It helps to identify the compatibility of donor and recipient by analyzing the antibody profile of blood samples. This test can be performed on any type of equipment such as HLA typing systems, ELISA kits, or microarrays.
Application Insights:
The pre-transfusion diagnostic segment dominated the global market in 2017. This can be attributed to a rise in demand for R&D activities related to blood transfusions and growing awareness among individuals regarding the benefits of these diagnostics tests. For instance, according to a study published by NCBI, it is estimated that around 60% of patients are aware about HLA typing and its significance while 40%of patients are not aware about this technology at all.
Moreover, another study carried out by researchers from ULCA found that majority of healthcare professionals do not have knowledge regarding compatibility issues between donor and recipient blood types which can lead to complications during surgery or any other medical procedure involving transfusion therapy. Therefore, pre-transfusion diagnostic testing is becoming increasingly popular as an efficient method for identifying potential risks associated with incompatible blood types which may require additional type O negative donors or Rh (D) immune globulin before surgery or any other medical procedures involving transfusions is performed on them.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare facilities, high adoption rate of advanced transfusion diagnostic and monitoring tools, and government initiatives for improving blood safety. For instance, in April 2018, a collaboration was launched by WHO and Uppsala University for Improving Blood Safety In Humanitarian Crises (PUCH). The research project aims at developing rapid tests to identify risks associated with bleeding disorders among war refugees & IDPs.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising patient awareness levels regarding blood donation & transfusion along with increasing prevalence of chronic diseases requiring blood donations leading to an increase in demand for transfusion diagnostic equipment such as laboratory testing services across emerging countries such as India & China. Moreover, growing medical tourism industry due to low cost treatment options will also boost regional growth over the forecast period.
Growth Factors:
- Increasing demand for transfusion diagnostic equipment due to rising incidence of blood disorders and cancer
- Technological advancements in transfusion diagnostic equipment that offer enhanced performance and accuracy
- Growing number of private and government-funded hospitals, clinics, and laboratories that are increasing the demand for transfusion diagnostic equipment
- Rising awareness about the benefits of early diagnosis of blood disorders through use of transfusion diagnostic equipment
- Increasing investments by manufacturers in research and development to develop new products
Scope Of The Report
Report Attributes
Report Details
Report Title
Transfusion Diagnostic Equipment Market Research Report
By Type
Molecular HLA Typing Diagnose Equipment, HLA Serology Diagnose Equipment, HLA Antibody Diagnostics Equipment
By Application
Pre-Transfusion Diagnostic, Post Transfusion Diagnostic
By Companies
Abbott, Immucor, Johnson & Johnson, Quotient, Beckman Coulter, Becton Dickinson, Biokit, BioMerieux, Siemens, Roche, Abbott, Diagast
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Transfusion Diagnostic Equipment Market Report Segments:
The global Transfusion Diagnostic Equipment market is segmented on the basis of:
Types
Molecular HLA Typing Diagnose Equipment, HLA Serology Diagnose Equipment, HLA Antibody Diagnostics Equipment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pre-Transfusion Diagnostic, Post Transfusion Diagnostic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Immucor
- Johnson & Johnson
- Quotient
- Beckman Coulter
- Becton Dickinson
- Biokit
- BioMerieux
- Siemens
- Roche
- Abbott
- Diagast
Highlights of The Transfusion Diagnostic Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular HLA Typing Diagnose Equipment
- HLA Serology Diagnose Equipment
- HLA Antibody Diagnostics Equipment
- By Application:
- Pre-Transfusion Diagnostic
- Post Transfusion Diagnostic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transfusion Diagnostic Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transfusion diagnostic equipment (TDE) is a medical device that helps to diagnose and monitor the health of patients who have received blood, plasma, platelets or other types of transfusions.
Some of the key players operating in the transfusion diagnostic equipment market are Abbott, Immucor, Johnson & Johnson, Quotient, Beckman Coulter, Becton Dickinson, Biokit, BioMerieux, Siemens, Roche, Abbott, Diagast.
The transfusion diagnostic equipment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transfusion Diagnostic Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transfusion Diagnostic Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transfusion Diagnostic Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transfusion Diagnostic Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transfusion Diagnostic Equipment Market Size & Forecast, 2020-2028
4.5.1 Transfusion Diagnostic Equipment Market Size and Y-o-Y Growth
4.5.2 Transfusion Diagnostic Equipment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Molecular HLA Typing Diagnose Equipment
5.2.2 HLA Serology Diagnose Equipment
5.2.3 HLA Antibody Diagnostics Equipment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pre-Transfusion Diagnostic
6.2.2 Post Transfusion Diagnostic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transfusion Diagnostic Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transfusion Diagnostic Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Molecular HLA Typing Diagnose Equipment
9.6.2 HLA Serology Diagnose Equipment
9.6.3 HLA Antibody Diagnostics Equipment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pre-Transfusion Diagnostic
9.10.2 Post Transfusion Diagnostic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Molecular HLA Typing Diagnose Equipment
10.6.2 HLA Serology Diagnose Equipment
10.6.3 HLA Antibody Diagnostics Equipment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pre-Transfusion Diagnostic
10.10.2 Post Transfusion Diagnostic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Molecular HLA Typing Diagnose Equipment
11.6.2 HLA Serology Diagnose Equipment
11.6.3 HLA Antibody Diagnostics Equipment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pre-Transfusion Diagnostic
11.10.2 Post Transfusion Diagnostic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Molecular HLA Typing Diagnose Equipment
12.6.2 HLA Serology Diagnose Equipment
12.6.3 HLA Antibody Diagnostics Equipment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pre-Transfusion Diagnostic
12.10.2 Post Transfusion Diagnostic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Molecular HLA Typing Diagnose Equipment
13.6.2 HLA Serology Diagnose Equipment
13.6.3 HLA Antibody Diagnostics Equipment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pre-Transfusion Diagnostic
13.10.2 Post Transfusion Diagnostic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transfusion Diagnostic Equipment Market: Competitive Dashboard
14.2 Global Transfusion Diagnostic Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Immucor
14.3.3 Johnson & Johnson
14.3.4 Quotient
14.3.5 Beckman Coulter
14.3.6 Becton Dickinson
14.3.7 Biokit
14.3.8 BioMerieux
14.3.9 Siemens
14.3.10 Roche
14.3.11 Abbott
14.3.12 Diagast
